case studies
Engineering Reliability Into Medical Device Box Builds — What Makes a Manufacturing Partner in Malaysia Dependable
/)
Flexi Versa Group
Engineering Reliability Into Medical Device Box Builds — What Makes a Manufacturing Partner in Malaysia Dependable
A mid-volume medical device OEM was preparing to scale production of a Class II diagnostic instrument — a benchtop device with a fluidics module, embedded PCBA, and a molded enclosure — from pilot runs into full commercial volume. The company had qualified a contract manufacturer in Malaysia for the box build: final assembly, integration of the fluidics and electronics subassemblies, functional test, and packaging. Six weeks before the first commercial shipment, a cluster of intermittent functional test failures appeared on the line, traced to inconsistent torque on a housing fastener sequence that was allowing micro-flex in the enclosure under vibration testing.
The Challenge
The failure rate was low — under 3% of units — but for a regulated medical device, an unexplained intermittent failure isn't a nuisance, it's a stop-ship issue until root cause is understood and controlled. The OEM's quality team couldn't release the commercial lot without a documented explanation, and the clock on their launch date was already tight.
A design-history-file gap: the fastening torque spec had never been validated against the enclosure's tolerance stack-up at commercial volumes.
Risk of a CAPA and potential field-failure exposure if the issue shipped undetected.
Schedule risk: the launch date was tied to a hospital system's procurement cycle, not easily moved.
Uncertainty about whether the defect was process-induced (assembly line) or design-induced (tolerance stack-up), which pointed to two very different fixes.
Limited internal bandwidth on the OEM side — their own engineering team was split across three other programs.
For a device going into clinical use, "probably fine" isn't a disposition. The OEM needed a partner who could isolate the mechanism, not just the symptom, and do it fast enough to protect the launch window.
The Solution
The manufacturing partner's process engineering team pulled the failed units off the line the same day the pattern was flagged and ran a structured root-cause investigation rather than defaulting to a blanket rework order. Their approach moved through several stages:
Containment first. All in-process and finished units from the affected lot were quarantined and 100% inspected against a temporary visual and functional checkpoint while the investigation ran, so the line didn't have to fully stop.
Fishbone and fastener audit. The team mapped every variable in the fastening step — torque driver calibration, fastener lot, operator technique, and enclosure dimensional variation — rather than assuming the assembly line was at fault.
Dimensional sampling. A sample of enclosures across multiple molding lots was measured against the CAD nominal, which surfaced a tolerance drift in one cavity of the multi-cavity mold tool that hadn't shown up in earlier low-volume runs.
Joint engineering review. The partner's process engineers and the OEM's design team reviewed findings together and agreed on a two-part fix: a tightened torque spec with a in-line torque-verification step, and a mold cavity correction scheduled with the molder.
Requalification. A revised process was piloted on a small batch, vibration-tested, and functionally verified before being rolled into the commercial line.
This wasn't a single fix — it was a design-and-process problem that needed both sides addressed to actually close out, not just mask the symptom on the assembly floor.
Technical Support & Collaboration
What mattered most to the OEM's quality lead wasn't just that the problem got solved — it was how the investigation was communicated while it was still open. The partner's process engineering lead was reachable directly, not through a general account inbox, and stood up a daily 15-minute call for the duration of the investigation so the OEM always knew what had been tested, what had been ruled out, and what was still open. Preliminary fishbone and dimensional data were shared as they came in rather than held until the full report was ready, which let the OEM's own regulatory team start drafting their CAPA documentation in parallel instead of waiting on a final report. When the root cause turned out to touch the mold tool — outside the box-build scope the OEM had originally contracted for — the partner flagged it immediately rather than quietly working around it, and helped coordinate directly with the molder to keep one point of accountability for the OEM.
The Outcome
The investigation closed with a documented, defensible root cause within days rather than weeks, which let the OEM's quality team finalize their CAPA and release the commercial lot without missing the launch window. The revised torque spec and in-line verification step have run since without a recurrence of the failure mode, and the corrected mold cavity brought the affected dimension back within spec on subsequent production lots. Beyond the immediate fix, the OEM gained a documented process change and inspection step they could point to during their next customer or notified-body audit — turning what started as a stop-ship risk into evidence of a controlled, responsive quality system.
Why It Worked
In-house process engineering, not just assembly labor. The partner had the technical depth to run a real root-cause investigation rather than defaulting to rework.
Direct engineer-to-engineer access. The OEM was talking to the people doing the investigation, not relayed through account management.
Willingness to flag scope beyond the contract. Surfacing the mold tool issue immediately, rather than absorbing it quietly, kept the OEM in control of a decision that was rightfully theirs.
Documentation built for a regulated environment. The investigation was captured in a form the OEM's quality team could use directly, understanding that in medical devices, an undocumented fix isn't a fix.
For a medical device OEM, the manufacturing partner isn't just executing a build spec — they're an extension of the quality system. This kind of engagement is what separates a box-build vendor from a partner: the difference shows up not when everything goes to plan, but when something doesn't, and shows up fast, transparently, and with the rigor a regulated product demands.
Frequently Asked Questions
What is a "box build" in medical device manufacturing? A box build refers to the final assembly stage where subassemblies — such as a PCBA, fluidics module, and enclosure — are integrated into the finished device, followed by functional testing and packaging. It's typically the last manufacturing step before a device is ready for distribution.
How is box build different from full turnkey contract manufacturing? Box build assumes the OEM (or another supplier) has already produced or sourced the major subassemblies, and the contract manufacturer focuses on integration, test, and packaging. Full turnkey manufacturing typically includes PCB fabrication, component sourcing, and subassembly production as well. Many medical device programs use a hybrid model, and the split of responsibility should be clearly defined in the manufacturing agreement.
Does a strong box-build partner eliminate the need for the OEM's own quality oversight? No. A capable manufacturing partner reduces risk and provides documentation the OEM's quality system can rely on, but the OEM retains ultimate responsibility for design controls, CAPA, and regulatory submissions. The partnership works best when it's treated as complementary to the OEM's quality system, not a replacement for it.
How should a medical device OEM evaluate a manufacturing partner's root-cause capability before an issue happens? Ask about their process engineering team's structure and whether investigations are led by dedicated engineers or by production supervisors. Request examples of past root-cause investigations (anonymized if needed) and ask how findings are documented and shared. A partner who can describe a structured methodology — not just "we fix it" — is a stronger signal than a low defect rate alone.
Why does manufacturing location matter for this kind of technical support? Time zone overlap and travel distance affect how quickly an OEM's team can get direct access to the people running an investigation, whether by call or in person. A partner in a major manufacturing hub with established medical device experience, like Malaysia, can offer both a mature regulatory-aware workforce and more practical accessibility than more distant options, though the deciding factor is still the specific team's expertise and communication practices.
Can dimensional or tolerance issues in molded enclosures really cause intermittent electronic or functional failures? Yes. Enclosure tolerance drift can create inconsistent mechanical loading on internal components, connectors, or fasteners, which may only manifest under specific conditions like vibration or thermal cycling — making it look like an intermittent electronic fault when the root cause is mechanical. This is why investigations that only look at the electronics can miss the actual cause.